Samlyn Capital, LLC Sage Therapeutics, Inc. Transaction History

Samlyn Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$18.62 - $26.95 $3.24 Million - $4.7 Million	-174,241 Reduced 22.66%	594,661 $11.1 Million
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $496,498 - $646,319	29,035 Added 3.92%	768,902 $16.7 Million
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $12.4 Million - $36.2 Million	739,867 New	739,867 $15.2 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.